Point72 Hong Kong LTD Pulmonx Corp Transaction History

Point72 Hong Kong LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$14.0 - $27.95 $22,582 - $45,083	-1,613 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$21.13 - $35.65 $34,082 - $57,503	1,613 New	1,613 $40,000
Q4 2021 Feb 14, 2022	SELL	$29.72 - $45.1 $17,297 - $26,248	-582 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$35.98 - $44.48 $7,879 - $9,741	-219 Reduced 27.34%	582 $21,000
Q2 2021 Aug 16, 2021	BUY	$37.61 - $48.0 $30,125 - $38,448	801 New	801 $35,000

124

30.8M

1.2K

1.2K

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $236M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.